Gene/Protein Disease Symptom Drug Enzyme Compound
Pivot Concepts:   Target Concepts:
Query: UMLS:C0009319 (colitis)
 19,384 document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)

A questionnaire was sent to 238 members of local pig discussion groups in the West Midlands region of England to identify farm level factors associated with the occurrence of diarrhoea in grower-finisher pigs. The questions related to the occurrence, diagnosis and aetiology of scour problems on the farm, the prevalence of common porcine diseases on the farm, the classes of pigs, staff employment, source of replacement stock and biosecurity measures, the husbandry techniques such as piglet management, use of medication, movement and mixing of pigs, dung removal and pen preparation between batches of pigs, and the physical resources such as floor type, pen divisions, watering, feeding and dung disposal systems. Replies from 105 producers keeping grower-finisher pigs were included in the analysis, 50.5 per cent of which had had a scour problem at some time in the previous three years. The causes of scour had been identified as colitis (34.3 per cent), swine dysentery (10.5 per cent) or porcine enteropathy (3.8 per cent). There was a significant association between the following factors and the occurrence of diarrhoea in grower-finisher pigs: the use of water medication for weaners (odds ratio = 11.8; P = 0.002), the tail-docking of piglets (odds ratio = 8.6; P = 0.003), the use of a wet feeding system for finishers (odds ratio = 5.9; P = 0.009), finishers housed on partially slatted floors (odds ratio = 3.6; P = 0.044), and the use of an isolation procedure for incoming breeding stock involving exposure to dung (odds ratio = 3.5; P = 0.046). The use of disinfectant in the preparation of pens between batches of pigs appeared to be protective (odds ratio = 0.3; P = 0.046).
 ...
PMID:Epidemiology of enteric disease in grower-finisher pigs: a postal survey of pig producers in England. 1023 11

Nuclear medicine is an important tool in the diagnostic evaluation of patients with a variety of nonosseous infections. In the immunocompetent population labeled leukocyte imaging is the radionuclide procedure of choice, with Gallium imaging reserved for those situations in which the leukocyte study is nondiagnostic or cannot be performed. Fever of unknown origin is caused by infection in less than one-third of cases, and therefore the number of positive leukocyte studies will be relatively low. The negative leukocyte study is also useful, however, as it has been demonstrated that a negative study excludes, with a high degree of certainty, focal infection as the cause of an FUO. In the cardiovascular system, labeled leukocyte scintigraphy is very useful for diagnosing mycotic aneurysms and infected prosthetic vascular grafts, with a sensitivity of about 90%. The specificity of the study is somewhat more variable--false positive results have been described in perigraft hematomas, graft thrombosis, bleeding, and pseudoaneurysms. In the central nervous system, labeled leukocyte imaging can provide important information about the etiology of contrast enhancing brain lesions identified on computed tomography, i.e., distinguishing between neoplasm and infection. In the immunocompromised population, typified by the AIDS patient, Gallium scintigraphy is the radionuclide procedure of choice for diagnosing opportunistic diseases. In the thorax, a normal Gallium scan, in the setting of a negative chest X-ray, virtually excludes pulmonary disease. A negative Gallium scan in a patient with an abnormal chest X-ray and Kaposi's sarcoma study suggests that the patient's respiratory problems are related to Kaposi's sarcoma. Focal pulmonary parenchymal uptake is most often associated with bacterial pneumonia, although Pneumocystis carinii pneumonia can occasionally present in this fashion. Diffuse pulmonary parenchymal uptake of Gallium can be due to numerous causes, but in general, the more intense the uptake, the greater the likelihood that the patient has P. carinii pneumonia. Lymph node uptake is most often due to lymphoma or mycobacterial disease. In the abdomen, Gallium is also useful for detecting nodal disease. but is not reliable for detecting large bowel disease. Labeled leukocyte imaging should be performed when colitis is a concern. Both 18FDG PET and 201Tl SPECT imaging of the brain are useful for distinguishing between central nervous system lymphoma and toxoplasmosis in the HIV (+) patient. On both studies, lymphoma manifests as a focus of increased tracer uptake, whereas toxoplasmosis shows little or no uptake of either tracer.
 ...
PMID:Radionuclide imaging of nonosseous infection. 1023 Feb 81

A 66-year-old woman was seen repeatedly over a decade to remove recurrent colonic adenomas and investigate episodes of watery diarrhea. Although the diarrhea was believed to be due to lymphocytic colitis, she developed weight loss, hypoproteinemia and hyposplenism that resulted in further studies, specifically to exclude celiac disease. Small intestinal biopsies, however, showed severely 'flattened' villous architecture with trichrome-positive subepithelial collagenous deposits, characteristic of collagenous sprue. Antiendomysial antibodies, known serological markers of celiac disease, were also detected. While collagenous sprue has been considered a distinct small intestinal disorder, the constellation of clinical and pathological findings in this patient suggests a close link with adult celiac disease.
 ...
PMID:Hyposplenism, antiendomysial antibodies and lymphocytic colitis in collagenous sprue. 1036 Sep 97

Autoimmune enteropathy is an increasingly recognized cause of severe protracted diarrhea, usually affecting infants and children predisposed to autoimmune phenomena. Although this may be a common cause of diarrheal illness, it is scarcely recognized in the American literature. In association with thymoma, a case of so-called graft-vs-host-like colitis and 2 cases of chronic diarrhea associated with thymoma were reported, but, to our knowledge, no cases of autoimmune enteropathy have been reported as such. We describe 2 adults with autoimmune enteropathy found in association with a thymoma.
 ...
PMID:Thymoma-associated autoimmune enteropathy. A report of two cases. 1058 4

Patients with inflammmatory bowel disease (IBD) have been reported to have an increased risk of colorectal cancer. Yet, the quantitation of the risk varies widely from one study to the next. This is most likely due to biases in the assessment of cancer risk in IBD, namely, a relatively low prevalence of IBD-related cancer and the clinically heterogeneous nature of IBD in the population. Total proctocolectomy also changes the natural history of IBD-related cancer. Ulcerative colitis (UC)-related cancer is more probable in total and extensive colitis and occurs approximately a decade after diagnosis. Crohn's disease-related colorectal cancer is reported in many, but not all, studies, and the relative risk differs between hospital- and population-based studies. IBD-related cancer is relatively uncommon in childhood; however, this is also a subject of debate. There are no data on the incidence of IBD-related cancer in Europe as a whole; there are only separate studies. A reduced risk for UC-related cancer in patients treated with anti-inflammatory drugs has been reported. The two main strategies for preventing IBD-related cancer are prophylactic colectomy and colonoscopic surveillance. To date, there have virtually been no cost-effectiveness analyses and no studies regarding total disease outcome or patient's quality of life with either strategy. No controlled, prospective trials have been reported in the literature. UC patients with familiar predisposition for colorectal cancer and with concomitant primary sclerosing cholangitis are groups at high risk for IBD-related cancer. Cancer risk in IBD has to be reinvestigated and properly estimated with population-based studies in several areas with standard methods already described.
 ...
PMID:Risk of cancer in inflammatory bowel disease (IBD). 1074 49

We studied the effect of recombinant human interleukin-11 (rhIL-11), a cytokine with protective effects against injury to the intestinal mucosa, on inflammatory changes in the muscle layers of the gut, in rabbits with colitis. A single dose of rhIL-11 (4, 40, or 720 microg/kg) was given 1 h before colitis was induced with 135 mg/kg 2, 4,6-trinitrobenzene sulfonic acid (TNBS), followed by a continuous s. c. administration of 4, 40, or 720 microg/kg. day rhIL-11 or saline for 5 days. Colitis affected mucosal architecture, general mechanical properties (passive tension increased with 12.3 g/mm(2), optimal stretch decreased with 26%), and collagen content (decreased from 366 +/- 25 to 237 +/- 13 microg/mg of protein). Changes in passive tension and collagen content were normalized by the highest and lowest dose of rhIL-11, respectively, but neither dose could normalize the optimal stretch. Colitis also decreased maximal contractile tension in response to acetylcholine (ACh), motilin, substance P (SP), K(+), and prostaglandin E(2) but this was normalized with 40 microg/kg. day (motilin, SP) and 720 microg/kg. day (ACh, K(+)) rhIL-11 but not for prostaglandin E(2). For motilin and SP, receptor density was decreased in colitis and normalized in treated rabbits. Colitis also increased the contractile potency toward ACh, an effect already reversed by rhIL-11, 4 microg/kg. day. In conclusion, rhIL-11 partially normalizes disturbed tension generation in experimental colitis. The use of this cytokine in the treatment of irritable bowel disease may contribute to the restoration of motor dysfunction.
 ...
PMID:Dose-dependent effects of recombinant human interleukin-11 on contractile properties in rabbit 2,4,6-trinitrobenzene sulfonic acid colitis. 1094 50

Aetiological diagnosis of protracted diarrhoea remains obscure in as many as 30% of cases despite extensive investigations. A number of newer syndromes have been recognized amongst this "idiopathic group" which includes microvillous inclusion disease, "tufting" enteropathy and epithelial dysplasia, autoimmune enteropathy and "syndromic" immunodeficiency with characteristic facial abnormalities, woolly hair and intractable diarrhea. The molecular basis of some of these syndromes has been reviewed but in only a small series of patients has the functional defect been characterized. If a case is suspected the antenatal history, family history and history of consanguinity should be sought. Extra-intestinal manifestations, presence of gut or other auto-antibodies, together with phenotypic abnormalities should be looked for. Careful light and electron microscopy is done of small bowel biopsies, although microvillous inclusion disease can be usually suspected on PAS staining. Large bowel biopsy may be needed to exclude an unsuspected microscopic colitis. The prognosis of this group of conditions is poor with an overall 50-85% mortality. Although successful gut transplantation has been reported, genetic counselling may be one of the more important aspects of the clinicians' role.
 ...
PMID:Newer diarrheal syndromes. 1113 69

Parenteral nutrition corrects for or prevents malnutrition in patients with acute or chronic bowel disease. Whether acute (a few days to a few weeks) or chronic (a few weeks to several years), there are two pathophysiological mechanisms of bowel disease leading to malnutrition: motricity disorders and defective absorption. Total parenteral nutrition has to be prescribed in three situations: occlusive intestinal stenosis, pseudo-obstruction with complete food intolerance, clinically or endoscopically severe colitis. The indication for total parenteral nutrition to allow the intestine to "rest" is indicated in case of digestive fistulae with a high flow and for inflammatory bowel disease (Crohn's disease, irradiated bowel disease). In other cases, parenteral nutrition can be used as a complement to poorly tolerated or quantitatively insufficient oral or enteral nutrition to maintain the patient's nutritional status or correct for malnutrition. Peripheral (<3 weeks) or central (>3 weeks) parenteral nutrition, like all types of nutritional support, must be complete and conducted according to a rigorous written protocol specific for each indication, particularly acute versus chronic intestinal disease, in order to avoid iatrogenic and metabolic risks. This goal can be best achieved by developing a nutritional team within each hospital. Two other important goals are to enhance the efficacy of the nutritional support and to avoid inappropriate prescriptions, notably for parenteral administration. Such an approach allows a better risk/benefit ratio evaluated with nutritional standards. These are the prerequisites for nutritional therapy to be recognized as a major discipline in medicine.
 ...
PMID:[Parenteral nutrition: indications and techniques]. 1117 9

The treatment of coeliac disease (CD) is straightforward and simple: life-long adherence to a gluten-free diet. However, in a small subgroup of patients, the clinical and histological abnormalities persist or recur. This non-responsiveness leaves a poorly understood syndrome known as refractory coeliac disease (RCD). A specific definition of RCD is lacking in the literature. We speculate that RCD may appear in a subgroup of coeliacs with persisting histologic abnormalities. In all patients screened for RCD we look for DQ2 and DQ8. In non-DQ2/DQ8 patients we reconsider the diagnosis of CD and of auto-immune enteropathy. Most of the patients referred to us because of suspicion of RCD are affected by other diseases. Probably the commonest cause of non-responsiveness is continued gluten intake. Exocrine pancreas insufficiency, hyperthyroid disease, collagenous colitis are other common explanations. RCD and enteropathy-associated T cell lymphomas (EATL) can be distinguished by intra-epithelial lymphocyte phenotyping and TCR-gamma gene rearrangements. In RCD, an unexplained sustained stimulation of T cell cytotoxic activity is present. Immunosuppressive treatment might moderate this. Cyclosporine has been reported as a resounding success in case reports; however, our results were disappointing. We suggest azathioprine and steroids in RCD without aberrant T-lymphocytes in their mucosa. However, in RCD with aberrant T-lymphocytes we suggest chemotherapy. As the prognosis of EATLs is extremely poor the early detection of RCD with aberrant T cells is crucial.
 ...
PMID:Refractory coeliac disease: a window between coeliac disease and enteropathy associated T cell lymphoma. 1123 88

Chronic inflammatory bowel disease (IBD)-like colitis is occasionally associated with glycogen storage disease-type 1b (GSD-1b). We describe a 17-year old boy with GSD-1b who developed an IBD-like colitis. Roentgenography and colonoscopy showed the lead-pipe appearance of the colon and circumferential ulcers. Histopathologic examination revealed nonspecific inflammation without granulomatous lesions. High-dose granulocyte-colony stimulating factor (G-CSF) and sulfasalazine led to the resolution of the colitis, although neutropenia continued. Besides this case, 10 published cases of GSD-1b and IBD-like colitis were reviewed. All cases had severe neutropenia and/or neutrophil dysfunction. The mean onset of bowel disease was 12.3 years of age. Seven cases required surgical treatment. All five patients with G-CSF/GM-CSF therapy showed clinical remission. These findings suggest that IBD-like colitis is a grave complication of GSD-1b and that recurrent enteric infections due to neutrophil deficiency may contribute to the development of this bowel disease.
 ...
PMID:Inflammatory bowel disease-like colitis in glycogen storage disease type 1b. 1138 85


<< Previous 1 2 3 4 5 6 7 8 9 10 Next >>